Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

VA Boston Healthcare System, Dana-Farber Cancer Institute, The University of Texas Southwestern Medical Center, University of California, San Francisco, Icahn School of Medicine at Mount Sinai, Sarah Cannon, Tennessee Oncology, Emory University, Massachusetts General Hospital, Mayo Clinic in Arizona, Hackensack University Medical Center, Institut Català d'Oncologia, Université de Lille, Institute for Translational Research in Inflammation, GNA University, Universitätsklinikum Würzburg, Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases, Universität Hamburg, Universitätsklinikum Tübingen, University Medical Center Hamburg-Eppendorf, University of Milan, Ospedale Papa Giovanni XXIII, Princess Margaret Cancer Centre, Bristol-Myers Squibb (Sweden), Navarre Institute of Health Research, Clinica Universidad de Navarra, Centro de Investigación Biomédica en Red de Cáncer